Kukjeon
국전 · 307750
Health Care Pharmaceuticals · KOSDAQ
Market cap US$100M (₩137.9B)
Overview
Kukjeon supplies active pharmaceutical ingredients, the core chemical compounds that give finished medicines their therapeutic effect, to drug makers developing generic, improved, and novel drugs, and also develops and supplies high-purity specialty chemical materials used in semiconductor packaging and OLED display manufacturing.
Its pharmaceutical customers rely on it across the full development pipeline, from early-stage research through regulatory approval to commercial production. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates two distinct divisions: a long-established pharmaceutical ingredients business and a newer advanced materials business supplying additives and antistatic agents for high-bandwidth memory chips and OLED common-layer materials.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$88.4M
- FY2024US$98.9M
- FY2025US$95M
Operating profit
- FY2023US$4.7M
- FY2024US$266.8K
- FY2025−US$1.9M
Net income
- FY2023US$3.4M
- FY2024US$389.6K
- FY2025−US$3.5M
Key ratios (FY2025)
Why it matters
The company is in the process of changing its registered name from Kukjeon Pharmaceutical to Kukjeon, reflecting its strategic expansion beyond pharmaceutical ingredients into advanced industrial materials.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?